earnings
confidence high
sentiment positive
materiality 0.75
Evolus Q2 revenue $37.2M (+42% YoY); reaffirms FY upper-end guidance $143-150M
Evolus, Inc.
2022-Q2 EPS reported
-$0.73
revenue$71,071,000
- Q2 net revenue $37.2M, up 42% YoY; gross margin 55.4% (adj. 57.4%); operating loss $21.3M.
- Reaffirms FY2022 revenue guidance upper end of $143-150M, expects ~50% YoY growth.
- Cash $84.5M; expects funding to cash-flow breakeven; Q4 gross margin step-up to 68-71% after royalty end.
- European Nuceiva launch on track for Q3 2022; Phase II 'extra strength' Jeuveau enrollment completed.
- Added 590 new customer accounts in Q2; total >8,100 purchasing customers; reorder rate >70%.